- Home
- Products
- Customized FluoroAb™
- CD19
- Blinatumomab-Bodipy FL
Blinatumomab-Bodipy FL (CAT#: ADC-FL-390)
This product is comprised of an anti-CD19 (scFv-kappa-heavy)-(scFv-heavy-kappa) antibody (Blinatumomab) labeled with Bodipy FL. Bodipy FL is a green-fluorescent dye and it's excitation/emission is 503/512 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- CD19
- Alternative Names
- CD19; CD19 molecule; CD19 antigen; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4; B4; CVID3; MGC12802;
- Overview
- Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
- Overview
- Anti-CD19 (scFv-kappa-heavy)-(scFv-heavy-kappa) antibody, Blinatumomab
- Generic name
- Blinatumomab
- Species Reactivity
- Human
- Name
- Bodipy FL
- Color
- Green
- Excitation⁄Emission (nm)
- 503/512
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-PDCD1 MAb (Clone 5)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12218)
- Namilumab-Cy5 (CAT#: ADC-FL-1005)
- Anti-TGFB1 MAb (Clone 6)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7656)
- Anti-ERBB2 MAb (Clone 2)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14056)
- Anti-VEGFA MAb (Clone 2)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16098)
- Anti-NGcGM3 MAb (Clone 1)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9999)
- Anti-CD37 MAb (Clone 9)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5659)
- Anti-HGF MAb (Clone 5)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15109)
- Anti-IL6 MAb (Clone 4)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6792)
- Anti-FAP MAb (Clone 5)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1069)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-390. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-2518 | Anti-CD19 (Denintuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-776 | Anti-CD19 (Blinatumomab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-778 | Anti-CD19 (Blinatumomab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-2516 | Anti-CD19 (Denintuzumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-780 | Anti-CD19 (Blinatumomab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
